SCHEMBL896381

SCHEMBL896381

CC1(C)C2C(C(F)(F)C(F)(F)C1(C)F)C(F)(F)C(F)(F)C(F)(F)C2(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL666416 0.82
SCHEMBL3150840 0.79
SCHEMBL11020464 0.76
SCHEMBL63607 0.74
SCHEMBL10410248 0.72
SCHEMBL1020860 0.71
SCHEMBL2509421 0.68
SCHEMBL28255549 0.65
SCHEMBL10409112 0.65
SCHEMBL10530579 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8513309-B2 Perfluorocarbons for use in treating pruritus OXYGEN BIOTHERAPEUTICS, INC. (US) 2013-08-20 US claimed
US-20120083510-A1 PERFLUOROCARBONS FOR USE IN TREATING PRURITUS TENAX THERAPEUTICS, INC 2012-04-05 US claimed
WO-2012044963-A2 PERFLUOROCARBONS FOR USE IN TREATING PRURITUS OXYGEN BIOTHERAPEUTICS, INC. (US) 2012-04-05 WO claimed
EP-1214586-B1 IMPLANTABLE GLUCOSE SENSOR OXYGEN BIOTHERAPEUTICS INC (US) 2010-03-24 EP claimed
US-6815186-B2 COMPRISES GLUCOSE OXIDASE EMULSION WITH PERFLUOROCARBON WHICH IS USED WITH MINIATURE POLAROGRAPHIC DEVICE; GELS IMPLANTED BIOSYSTEMS, INC. 2004-11-09 US claimed
WO-2001020019-A9 IMPLANTABLE GLUCOSE SENSOR IMPLANTED BIOSYSTEMS INC (US) 2002-08-29 WO claimed
EP-1214586-A2 IMPLANTABLE GLUCOSE SENSOR Implanted Biosystems, Inc. (US) 2002-06-19 EP claimed
US-20020068860-A1 Implantable glucose sensor IMPLANTED BIOSYSTEMS, INC. 2002-06-06 US claimed
US-6343225-B1 SENSOR PROVIDING OXYGEN RESERVOIR IN INTIMATE CONTACT WITH OXIDATIVE ENZYME BY MAKING EMULSION OF ENZYME AND COMPOUND IN WHICH OXYGEN IS EXTREMELY SOLUBLE AND STABILIZING BY CROSSLINKING MIXTURE TO FORM GEL IMPLANTED BIOSYSTEMS, INC. 2002-01-29 US claimed
WO-2001020019-A2 IMPLANTABLE GLUCOSE SENSOR IMPLANTED BIOSYSTEMS, INC. (US) 2001-03-22 WO claimed
US-20220379559-A1 RESIN CASSETTES WITH LIQUID INHIBITOR BEDS TO MINIMIZE GHOSTING DURING ADDITIVE MANUFACTURING CARBON INC (US) 2022-12-01 US disclosed
US-11446871-B2 Resin cassettes with liquid inhibitor beds to minimize ghosting during additive manufacturing CARBON, INC. (US) 2022-09-20 US disclosed
US-20210094231-A1 RESIN CASSETTES WITH LIQUID INHIBITOR BEDS TO MINIMIZE GHOSTING DURING ADDITIVE MANUFACTURING CARBON INC (US) 2021-04-01 US disclosed
US-8513309-B2 Perfluorocarbons for use in treating pruritus OXYGEN BIOTHERAPEUTICS, INC. (US) 2013-08-20 US disclosed
US-20130096190-A1 PERFLUOROCARBON GEL FORMULATIONS OXYGEN BIOTHERAPEUTICS, INC. (US) 2013-04-18 US disclosed
US-20020068860-A1 Implantable glucose sensor IMPLANTED BIOSYSTEMS, INC. 2002-06-06 US disclosed
US-6343225-B1 SENSOR PROVIDING OXYGEN RESERVOIR IN INTIMATE CONTACT WITH OXIDATIVE ENZYME BY MAKING EMULSION OF ENZYME AND COMPOUND IN WHICH OXYGEN IS EXTREMELY SOLUBLE AND STABILIZING BY CROSSLINKING MIXTURE TO FORM GEL IMPLANTED BIOSYSTEMS, INC. 2002-01-29 US disclosed
WO-2001020019-A2 IMPLANTABLE GLUCOSE SENSOR IMPLANTED BIOSYSTEMS, INC. (US) 2001-03-22 WO disclosed
US-5180676-A Suspension of cells in a liquid fluorocarbon having dissolved oxygen in a culture medium TEIJIN LIMITED (JP) 1993-01-19 US disclosed
EP-0164813-B1 METHOD OF CULTIVATING ANIMAL OR PLANT CELLS TEIJIN LIMITED (JP) 1991-10-09 EP disclosed